Efficacy of the Kyoto Classification of Gastritis in Identifying Patients at High Risk for Gastric Cancer

• Published in: Internal Medicine Vol. 56; no. 6; pp. 579 - 586
• Main Authors: Otsuka, Taketo, Ban, Hiromitsu, Sahara, Shu, Andoh, Akira, Inatomi, Osamu, Furuta, Takahisa, Sugimoto, Mitsushige, Ichikawa, Hitomi, Bamba, Shigeki
• Format: Journal Article
• Language: English
• Published: Japan The Japanese Society of Internal Medicine 01.01.2017; Japan Science and Technology Agency
• Subjects: Aged; Atrophy; Atrophy - pathology; Classification; Eradication; Female; Gastric cancer; Gastric Mucosa - pathology; Gastritis; Gastritis - epidemiology; Gastritis - pathology; Helicobacter Infections - epidemiology; Helicobacter Infections - pathology; Helicobacter pylori; Humans; Hypertrophy; Internal medicine; Intestine; Male; mass screening/MT; Metaplasia; Middle Aged; Multivariate analysis; Original; Prevalence; risk assessment; Risk Factors; Stomach Neoplasms - epidemiology; Stomach Neoplasms - pathology
• ISSN: 0918-2918; 1349-7235; 1349-7235
• DOI: 10.2169/internalmedicine.56.7775

Objective The Kyoto gastritis classification categorizes the endoscopic characteristics of Helicobacter pylori (H. pylori) infection-associated gastritis and identifies patterns associated with a high risk of gastric cancer. We investigated its efficacy, comparing scores in patients with H. pylori-associated gastritis and with gastric cancer. Methods A total of 1,200 patients with H. pylori-positive gastritis alone (n=932), early-stage H. pylori-positive gastric cancer (n=189), and successfully treated H. pylori-negative cancer (n=79) were endoscopically graded according to the Kyoto gastritis classification for atrophy, intestinal metaplasia, fold hypertrophy, nodularity, and diffuse redness. Results The prevalence of O-II/O-III-type atrophy according to the Kimura-Takemoto classification in early-stage H. pylori-positive gastric cancer and successfully treated H. pylori-negative cancer groups was 45.1%, which was significantly higher than in subjects with gastritis alone (12.7%, p<0.001). Kyoto gastritis scores of atrophy and intestinal metaplasia in the H. pylori-positive cancer group were significantly higher than in subjects with gastritis alone (all p<0.001). No significant differences were noted in the rates of gastric fold hypertrophy or diffuse redness between the two groups. In a multivariate analysis, the risks for H. pylori-positive gastric cancer increased with intestinal metaplasia (odds ratio: 4.453, 95% confidence interval: 3.332-5.950, <0.001) and male sex (1.737, 1.102-2.739, p=0.017). Conclusion Making an appropriate diagnosis and detecting patients at high risk is crucial for achieving total eradication of gastric cancer. The scores of intestinal metaplasia and atrophy of the scoring system in the Kyoto gastritis classification may thus be useful for detecting these patients.